259 related articles for article (PubMed ID: 24829283)
1. Interplay between Mdm2 and HIPK2 in the DNA damage response.
Zhang XP; Liu F; Wang W
J R Soc Interface; 2014 Jul; 11(96):. PubMed ID: 24829283
[TBL] [Abstract][Full Text] [Related]
2. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.
Nardinocchi L; Puca R; Givol D; D'Orazi G
FEBS Lett; 2010 Oct; 584(19):4253-8. PubMed ID: 20849851
[TBL] [Abstract][Full Text] [Related]
3. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
[TBL] [Abstract][Full Text] [Related]
4. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.
Rinaldo C; Prodosmo A; Mancini F; Iacovelli S; Sacchi A; Moretti F; Soddu S
Mol Cell; 2007 Mar; 25(5):739-50. PubMed ID: 17349959
[TBL] [Abstract][Full Text] [Related]
5. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
[TBL] [Abstract][Full Text] [Related]
6. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
[TBL] [Abstract][Full Text] [Related]
7. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S
Oncogene; 2011 Dec; 30(48):4802-13. PubMed ID: 21602882
[TBL] [Abstract][Full Text] [Related]
8. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.
Nardinocchi L; Puca R; Sacchi A; Rechavi G; Givol D; D'Orazi G
PLoS One; 2009 Aug; 4(8):e6819. PubMed ID: 19714248
[TBL] [Abstract][Full Text] [Related]
9. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function.
Di Stefano V; Blandino G; Sacchi A; Soddu S; D'Orazi G
Oncogene; 2004 Jul; 23(30):5185-92. PubMed ID: 15122315
[TBL] [Abstract][Full Text] [Related]
10. HIPK2 regulation by MDM2 determines tumor cell response to the p53-reactivating drugs nutlin-3 and RITA.
Rinaldo C; Prodosmo A; Siepi F; Moncada A; Sacchi A; Selivanova G; Soddu S
Cancer Res; 2009 Aug; 69(15):6241-8. PubMed ID: 19638586
[TBL] [Abstract][Full Text] [Related]
11. Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.
Akaike Y; Kuwano Y; Nishida K; Kurokawa K; Kajita K; Kano S; Masuda K; Rokutan K
Oncogene; 2015 Jun; 34(26):3463-73. PubMed ID: 25151962
[TBL] [Abstract][Full Text] [Related]
12. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
Puca R; Nardinocchi L; Givol D; D'Orazi G
Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
[TBL] [Abstract][Full Text] [Related]
13. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.
Dauth I; Krüger J; Hofmann TG
Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358
[TBL] [Abstract][Full Text] [Related]
14. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
[TBL] [Abstract][Full Text] [Related]
15. XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.
Lee MG; Han J; Jeong SI; Her NG; Lee JH; Ha TK; Kang MJ; Ryu BK; Chi SG
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15532-7. PubMed ID: 25313037
[TBL] [Abstract][Full Text] [Related]
16. Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization.
Polonio-Vallon T; Kirkpatrick J; Krijgsveld J; Hofmann TG
Cell Cycle; 2014; 13(1):115-25. PubMed ID: 24196445
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia triggers HIPK2 protein degradation.
Baldari S; Garufi A; Granato M; Cuomo L; Pistritto G; Cirone M; D'Orazi G
Oncotarget; 2017 Jan; 8(1):1190-1203. PubMed ID: 27901482
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2.
Muschik D; Braspenning-Wesch I; Stockfleth E; Rösl F; Hofmann TG; Nindl I
PLoS One; 2011; 6(11):e27655. PubMed ID: 22110707
[TBL] [Abstract][Full Text] [Related]
19. A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation.
Valentine JM; Kumar S; Moumen A
BMC Cancer; 2011 Feb; 11():79. PubMed ID: 21338495
[TBL] [Abstract][Full Text] [Related]
20. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
